Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Journal
This editorial from The Lancet Respiratory Medicine discusses the growing public health crisis of Long COVID. It highlights that over 65 million people worldwide are estimated to have post-acute sequelae of COVID-19, and there is an urgent need for preventive, rehabilitative, and therapeutic strategies to address this issue. The article emphasizes the importance of vaccination against SARS-CoV-2 in reducing the risk of Long COVID and mentions the potential benefits of early outpatient treatment in preventing it. However, challenges remain in defining Long COVID, diagnosing it reliably, and understanding its causes and mechanisms. The article calls for large-scale research initiatives to explore these aspects, identify diagnostic and prognostic biomarkers, and develop targeted interventions. It also emphasizes the importance of considering the needs of vulnerable populations and providing patient-centered care for Long COVID.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This study investigates deaf American Sign Language (ASL) users’ access to telehealth and outpatient encounters during the pandemic. The findings emphasize the importance of optimizing proactive accommodation planning and access including in telehealth platforms.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This article discusses strategies to promote equity in COVID-19 antiviral treatment. It highlights the disproportionate effect of the pandemic on marginalized groups and the need to address inequities in access to antiviral medications. The authors discuss barriers to equity, such as low awareness, limited access to healthcare, scarcity of therapeutics, and treatment prioritization. They propose strategies to overcome these barriers, including community-driven outreach campaigns, addressing healthcare costs for uninsured patients, transparent allocation of therapeutics, and monitoring data to ensure equity. The article emphasizes the importance of proactive and transparent approaches to promote health equity in COVID-19 treatment.